NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
May 4, 2020
Four North Carolina universities have teamed up to win a $5.7 million federal grant for diabetes research.
May 4, 2020
CED's Venture Connect Online starts today and runs for the next three weeks, giving over 90 growth-stage companies exposure to potential investors from around the world.
April 30, 2020
Banner Life Sciences, a High Point pharmaceutical company, has gained final regulatory approval of a drug for treating multiple sclerosis.
April 30, 2020
Durham-based Chimerix is another step closer to getting the final go-ahead for its novel smallpox treatment.
April 30, 2020
Durham-based Chimerix has gotten the green light from the FDA to test an investigational cancer drug to treat COVID-19 patients.
April 29, 2020
First Flight Venture Center has named Krista Covey as the incubator’s new president, effective May 18.
April 29, 2020
For those feeling the health and economic heat from COVID-19 – and that’s just about everyone – Heat Biologics says it could soon offer up a potential solution.
April 28, 2020
A LabCorp blood test that helps identify individuals who’ve been exposed to the COVID-19 coronavirus is now broadly available.
April 27, 2020
Duke University biomedical engineers are using an NSF grant to convert a rapid testing platform originally designed to detect Ebola to catch antigens to COVID-19.
April 27, 2020
RedHill Biopharma, an Israeli specialty company with U.S. headquarters in Raleigh, says all six COVID-19 patients who recently received its investigative drug, opaganib, got better.
April 23, 2020
Wake Forest University researchers have a $3 million NSF grant to study why tomato plants won’t bear fruit when things get hot.
April 23, 2020
Morrisville precision health company Metabolon is working with a Seattle non-profit to study variations in COVID-19 outcomes and target potential therapies to deal with those variations.
April 22, 2020
AskBio has acquired BrainVectis, a French company that is developing a potential gene therapy for Huntington’s disease, a fatal genetic disease of the brain.
April 22, 2020
People who have recovered from COVID-19 may donate potentially lifesaving plasma at UNC, and Grifols is also collecting it at plasma donor sites elsewhere around the country.
April 22, 2020
Healthcare workers and first responders who have symptoms of COVID-19 now can use a LabCorp kit to self-test for the coronavirus at home.